A Phase 2 Study of Radium-223 and Radiotherapy in Hormone-Naïve Men With Oligometastatic Prostate Cancer to Bone
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2018
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms RROPE
- 12 Feb 2018 Status changed from not yet recruiting to recruiting.
- 14 Dec 2017 Planned initiation date changed from 1 Nov 2017 to 1 Feb 2018.
- 11 Oct 2017 New trial record